Tag Archives: Firm known for HIV treatment set to begin live test of coronavirus drug

WASHINGTON: A US biotech firm Gilead has reached an agreement with China to try its antiviral drug Rem­desivir on patients with coronavirus. Gilead is known for its HIV and hepatitis C treatments but its efforts to find a cure for the deadly respiratory disease drew attention when a US medical journal carried a case report earlier this week. The New …

Read More »